DRW Securities LLC lowered its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 59.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,209 shares of the financial services provider’s stock after selling 1,791 shares during the quarter. DRW Securities LLC’s holdings in CME Group were worth $267,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in CME. Harbor Capital Advisors Inc. lifted its stake in shares of CME Group by 0.6% during the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock valued at $1,723,000 after acquiring an additional 45 shares during the period. CVA Family Office LLC lifted its position in CME Group by 11.8% during the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after purchasing an additional 46 shares during the period. Lester Murray Antman dba SimplyRich boosted its stake in shares of CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after purchasing an additional 50 shares during the last quarter. Zions Bancorporation N.A. grew its position in shares of CME Group by 3.7% during the 3rd quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock worth $338,000 after buying an additional 54 shares during the period. Finally, Quent Capital LLC raised its stake in shares of CME Group by 10.2% during the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock worth $131,000 after buying an additional 55 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.
Analysts Set New Price Targets
A number of analysts have commented on the stock. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a report on Tuesday, October 8th. Morgan Stanley lifted their price objective on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. TD Cowen assumed coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price on the stock. Deutsche Bank Aktiengesellschaft decreased their target price on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $235.00 price target on shares of CME Group in a research report on Thursday, October 24th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, CME Group has a consensus rating of “Hold” and a consensus target price of $224.47.
Insider Activity
In related news, Director Timothy S. Bitsberger sold 1,000 shares of the stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total transaction of $226,960.00. Following the completion of the transaction, the director now directly owns 10,589 shares of the company’s stock, valued at approximately $2,403,279.44. This represents a 8.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 12.01 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 over the last ninety days. Insiders own 0.30% of the company’s stock.
CME Group Trading Up 1.3 %
Shares of NASDAQ:CME opened at $237.33 on Thursday. The firm has a market cap of $85.52 billion, a price-to-earnings ratio of 24.96, a PEG ratio of 5.29 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $238.12. The company’s fifty day simple moving average is $224.60 and its 200 day simple moving average is $211.56.
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same quarter last year, the business posted $2.25 EPS. As a group, research analysts forecast that CME Group Inc. will post 10.22 EPS for the current fiscal year.
CME Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be paid a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 1.94%. CME Group’s dividend payout ratio is currently 48.37%.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- 3 Fintech Stocks With Good 2021 Prospects
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Are Dividends? Buy the Best Dividend Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Use Stock Screeners to Find Stocks
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.